Blood Collection From Heart Failure Patients to Evaluate for Galectin-3 Measurement Differences Using Various Collection Tubes

N/ACompletedNCT01980862

Fujirebio Diagnostics, Inc.48 enrolled

Overview

Single-site blood collection investigation.

45 Heart Failure patients will be recruited. Patients will provide a one-time blood sample specimen collection. Theses samples will be de-identified and provided for measurement of Galectin-3 on commercial platforms.

Study Type

OBSERVATIONAL

Enrollment

Conditions

To Measure Galectin-3 in Heart Failure Patients on Commercial Platforms

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Heart Failure patients New York Heart Association class able to provide (4) collection tube types Subjects \> 18 years old All subjects must provide informed consent and associated documentation Exclusion Criteria: * Subjects that cannot tolerate blood withdrawal of 4 specimens collection tube tubes (approximately 40 mLs)

Locations (1)

University of Maryland School of Medicine

Baltimore, Maryland, United States

Outcomes

Primary Outcomes

Obtain 45 matched donor serum and plasma samples sets collected from Heart Failure patients for galectin-3 measurements

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.